GCEPX
Price
$9.94
Change
-$0.03 (-0.30%)
Updated
Sep 16 closing price
Net Assets
37.49M
VCRVX
Price
$14.50
Change
-$0.12 (-0.82%)
Updated
Sep 16 closing price
Net Assets
N/A
Interact to see
Advertisement

GCEPX vs VCRVX

Header iconGCEPX vs VCRVX Comparison
Open Charts GCEPX vs VCRVXBanner chart's image
Goldman Sachs Clean Energy Income P
Price$9.94
Change-$0.03 (-0.30%)
VolumeN/A
Net Assets37.49M
NYLI CBRE Global Infrastructure Inv Cl
Price$14.50
Change-$0.12 (-0.82%)
VolumeN/A
Net AssetsN/A
GCEPX vs VCRVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCEPX vs. VCRVX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCEPX is a StrongBuy and VCRVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GCEPX (1.78) and VCRVX (1.70) have matching dividends . GCEPX was incepted earlier than VCRVX: GCEPX (5 years) vs VCRVX (6 years). GCEPX (1.42) is less costly to investors than VCRVX (1.35). GCEPX is a more actively managed with annual turnover of: 136.00 vs. VCRVX (81.00). GCEPX has a lower initial minimum investment than VCRVX: GCEPX (0) vs VCRVX (1000). VCRVX annual gain was more profitable for investors over the last year : 7.04 vs. GCEPX (0.65). VCRVX return over 5 years is better than : 42.20 vs. GCEPX (-4.00).
GCEPXVCRVXGCEPX / VCRVX
Total Expense Ratio0.881.3565%
Annual Report Gross Expense Ratio1.421.35105%
Fund Existence5 years6 years-
Gain YTD23.98912.363194%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets37.5MN/A-
Annual Yield % from dividends1.781.70105%
Returns for 1 year0.657.049%
Returns for 3 years-17.0821.72-79%
Returns for 5 years-4.0042.20-9%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRLT2.380.02
+0.85%
Brilliant Earth Group
PLD114.030.77
+0.68%
PROLOGIS
CADL4.85N/A
N/A
Candel Therapeutics
DMLP25.39-0.04
-0.16%
Dorchester Minerals LP
AXSM114.10-2.68
-2.29%
Axsome Therapeutics